Cupressus Sempervirence crude extract on superficial basal cell carcinoma kinetics

Evaluation of Cupressus Sempervirence crude extract on superficial basal cell carcinoma kinetics

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120524009844N11

Enrollment

Registered

2024-01-31

Start date

2024-02-20

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial basal cell carcinoma. Basal cell carcinoma of skin of scalp and neck

Interventions

Intervention 1: Intervention group: This group will be treated with cryotherapy along with topical cream prepared from cypress plant extract twice a day for 6 weeks. (All patients are candidates for s

therefore, patients will not be deprived of routine treatment). Intervention 2: Control group: This will serve as a control group and will not receive any intervention. (All patients are candidates fo

therefore, patients will not be deprived of routine treatment).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with inoperable superficial basal cell carcinoma Consent to participate in the study

Exclusion criteria

Exclusion criteria: Lack of consent to participate in the study Lesions that have found local invasion

Design outcomes

Primary

Measure	Time frame
Lesion diameter. Timepoint: Before the intervention, 1 week, 2 weeks, 3 weeks and 4 weeks after the intervention. Method of measurement: Caliper.;The unwanted side effect of medicine. Timepoint: One month after the intervention. Method of measurement: Clinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Amirnia

Tabriz University of Medical Sciences

mehamiruo@gmail.com+98 41 3541 2101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026